STAT+: Will Novo Nordisk’s slashing of obesity drug prices save patients’ money? It depends
STAT [Unofficial]
February 24, 2026
Will Novo Nordisk’s slashing of obesity drug prices save patients’ money or expand access? It depends.
Discussion in the ATmosphere